Core Laboratories (NYSE:CLB) Downgraded by Wall Street Zen to Sell

Wall Street Zen downgraded shares of Core Laboratories (NYSE:CLB) from a hold rating to a sell rating in a research note issued to investors on Saturday morning.

Separately, Weiss Ratings downgraded shares of Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Four equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Stock Down 2.3%

CLB stock opened at $13.15 on Friday. The company has a market cap of $605.98 million, a price-to-earnings ratio of 20.22, a PEG ratio of 2.47 and a beta of 0.99. The company has a 50 day moving average of $16.40 and a two-hundred day moving average of $16.80. The company has a quick ratio of 1.50, a current ratio of 2.05 and a debt-to-equity ratio of 0.42. Core Laboratories has a 12-month low of $9.72 and a 12-month high of $20.36.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.06. The business had revenue of $121.80 million for the quarter, compared to the consensus estimate of $122.99 million. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. Core Laboratories’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.14 EPS. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. On average, equities analysts anticipate that Core Laboratories will post 0.57 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Monday, May 11th will be issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, May 11th. Core Laboratories’s dividend payout ratio (DPR) is 6.15%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. CWA Asset Management Group LLC bought a new position in Core Laboratories in the 4th quarter worth $9,978,000. Pacific Ridge Capital Partners LLC bought a new position in Core Laboratories in the 3rd quarter worth $525,000. Intech Investment Management LLC raised its holdings in Core Laboratories by 6.7% in the 3rd quarter. Intech Investment Management LLC now owns 44,504 shares of the oil and gas company’s stock worth $550,000 after acquiring an additional 2,801 shares during the period. FourThought Financial Partners LLC bought a new position in Core Laboratories in the 3rd quarter worth $310,000. Finally, Fox Run Management L.L.C. raised its holdings in Core Laboratories by 5.9% in the 3rd quarter. Fox Run Management L.L.C. now owns 18,531 shares of the oil and gas company’s stock worth $229,000 after acquiring an additional 1,038 shares during the period. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.